Close Menu

NEW YORK (GenomeWeb) – Luminex said today that the US Food and Drug Administration has granted 510(k) clearance for its Aries Group A Strep Assay, a moderate complexity, sample-to-answer test for the direct detection of Streptococcus pyogenes from throat swab specimens using the Aries System.

The firm noted that it is the sixth assay that the FDA has cleared for use on its Aries systems in the last 24 months.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Financial Times reports the US bolstering its ability to track SARS-CoV-2 alterations.

The New York Times reports that Cedars-Sinai researchers have uncovered a new strain of SARS-CoV-2 in Southern California.

In Nucleic Acids Research this week: pan-cancer atlas focus on miRNA biogenesis mutations, methylation analysis of pig skeletal muscles, and more.

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.